US Patent Issued to INSTITUTE FOR CANCER RESEARCH on July 7 for "Systems and methods for treating patients having a genetic predisposition to develop prostate cancer" (Pennsylvania Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,206, issued on July 7, was assigned to INSTITUTE FOR CANCER RESEARCH (Philadelphia).

"Systems and methods for treating patients having a genetic predisposition to develop prostate cancer" was invented by Sanjeevani Arora (Philadelphia), Greg Enders (Philadelphia), Erica Golemis (Philadelphia), Emmanuelle Nicolas (Philadelphia) and Ilya Serebriiskii (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Systems and methods for mitigating prostate cancer development are provided. Peripheral blood cells may be evaluated for the presence or quantity of gamma-H2AX foci, and/or for gene alterations encoding a protein with impaired or lack of function...